EKR Therapeutics

Cornerstone Therapeutics buys IV blood pressure drug maker EKR in deal worth up to $150M
Yahoo/AP
Wed, 06/27/12 - 12:46 pm
Cornerstone Therapeutics
EKR Therapeutics
M&A